Literature DB >> 28078383

Effects of Triple Cryoenergy Application on Lesion Formation and Coronary Arteries in the Developing Myocardium.

Ulrich Krause1, Filipe D Abreu da Cunha2, David Backhoff2, Claudius Jacobshagen3, Sophia Klehs2, Heike E Schneider2, Thomas Paul2.   

Abstract

To improve long-term outcome after cryoablation of substrates of supraventricular tachycardia, application of two and three consecutive freeze-thaw cycles has been performed. The effect of triple freeze-thaw cycles on lesion formation within developing myocardium and coronary arteries, however, has not been studied yet. In eight piglets (mean age 15 weeks, weight 15-20 kg), 30 cryolesions (three consecutive freeze-thaw cycles) were applied to the atrial aspect of both AV valve annuli (n = 18) as well as to ventricular myocardium below the valves (n = 12). Coronary angiography was performed before and after cryoenergy application. The animals were reevaluated by coronary angiography and intracoronary ultrasound (ICUS) after 48 h. All hearts were removed for histological examination of the lesions subsequently. After staining (hematoxylin-eosin, desmin immunohistochemistry), lesions was measured by planimetry with a digital virtual miscroscope analysis system and volumes of the cryolesions were calculated. Mean atrial lesion volume was 190.68 ± 167.53 mm3 (n = 18), and mean ventricular lesion volume was 184.34 ± 107.42 mm3 (n = 12). Compared with previously reported data on lesion volumes after single and double freeze-thaw cycles, lesions were significantly larger. Coronary arteries were unaffected on coronary angiography as well as on ICUS. No affection of coronary arteries was found on histological examination. Application of three consecutive freeze-thaw cycles resulted in increased lesion volume compared with single and double freeze-thaw cycles. No affection of the coronary arteries was evident. To evaluate the clinical benefit and safety of triple cryoenergy application for catheter ablation, prospective randomized trials are required.

Entities:  

Keywords:  Catheter ablation; Coronary artery; Cryoenergy; Developing myocardium; Supraventricular tachycardia

Mesh:

Year:  2017        PMID: 28078383     DOI: 10.1007/s00246-016-1564-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  19 in total

1.  PACES/HRS expert consensus statement on the management of the asymptomatic young patient with a Wolff-Parkinson-White (WPW, ventricular preexcitation) electrocardiographic pattern: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), the American Academy of Pediatrics (AAP), and the Canadian Heart Rhythm Society (CHRS).

Authors:  Mitchell I Cohen; John K Triedman; Bryan C Cannon; Andrew M Davis; Fabrizio Drago; Jan Janousek; George J Klein; Ian H Law; Fred J Morady; Thomas Paul; James C Perry; Shubhayan Sanatani; Ronn E Tanel
Journal:  Heart Rhythm       Date:  2012-05-10       Impact factor: 6.343

2.  Double cryoenergy application (freeze-thaw-freeze) at growing myocardium: lesion volume and effects on coronary arteries early after energy application. Implications for efficacy and safety in pediatric patients.

Authors:  Heike E Schneider; Maja Stahl; Thomas Kriebel; Wolfgang Schillinger; Manfred Schill; Johannes Jakobi; Thomas Paul
Journal:  J Cardiovasc Electrophysiol       Date:  2013-03-07

3.  Cryothermal ablation of the slow pathway for the elimination of atrioventricular nodal reentrant tachycardia.

Authors:  A C Skanes; M Dubuc; G J Klein; B Thibault; A D Krahn; R Yee; D Roy; P Guerra; M Talajic
Journal:  Circulation       Date:  2000-12-05       Impact factor: 29.690

4.  Efficacy and safety of cryoenergy in the ablation of atrioventricular reentrant tachycardia substrates in children and adolescents.

Authors:  Thomas Kriebel; Claudia Broistedt; Maja Kroll; Matthias Sigler; Thomas Paul
Journal:  J Cardiovasc Electrophysiol       Date:  2005-09

Review 5.  Cryoablation of atrial arrhythmias.

Authors:  Allan C Skanes; Raymond Yee; Andrew D Krahn; George J Klein
Journal:  Card Electrophysiol Rev       Date:  2002-12

6.  Safety and results of cryoablation in patients <5 years old and/or <15 kilograms.

Authors:  Martin J LaPage; John H Reed; Kathryn K Collins; Ian H Law; Thomas A Pilcher; Ronn E Tanel; Charles C Anderson; Ming-Lon Young; Mathias Emmel; Thomas Paul; Andrew D Blaufox; Gaurav Arora; J Philip Saul
Journal:  Am J Cardiol       Date:  2011-05-31       Impact factor: 2.778

7.  Pharmacological and non-pharmacological therapy for arrhythmias in the pediatric population: EHRA and AEPC-Arrhythmia Working Group joint consensus statement.

Authors:  Josep Brugada; Nico Blom; Georgia Sarquella-Brugada; Carina Blomstrom-Lundqvist; John Deanfield; Jan Janousek; Dominic Abrams; Urs Bauersfeld; Ramon Brugada; Fabrizio Drago; Natasja de Groot; Juha-Matti Happonen; Joachim Hebe; Siew Yen Ho; Eloi Marijon; Thomas Paul; Jean-Pierre Pfammatter; Eric Rosenthal
Journal:  Europace       Date:  2013-07-12       Impact factor: 5.214

8.  Cryoablation of typical atrioventricular nodal reentrant tachycardia in children: six years' experience and follow-up in a single center.

Authors:  Fabrizio Drago; Mario S Russo; Massimo S Silvetti; Antonella DE Santis; Francesca Iodice; Maria Teresa Naso Onofrio
Journal:  Pacing Clin Electrophysiol       Date:  2009-12-01       Impact factor: 1.976

9.  Incidence of coronary artery injury immediately after catheter ablation for supraventricular tachycardias in infants and children.

Authors:  Heike E Schneider; Thomas Kriebel; Verena D Gravenhorst; Thomas Paul
Journal:  Heart Rhythm       Date:  2009-02-25       Impact factor: 6.343

10.  Morphometric ablation lesion characteristics comparing 4, 6, and 8 mm electrode-tip cryocatheters.

Authors:  Paul Khairy; Lena Rivard; Peter G Guerra; Jean-François Tanguay; Wadi Mawad; Denis Roy; Mario Talajic; Bernard Thibault; Laurent Macle; Marc Dubuc
Journal:  J Cardiovasc Electrophysiol       Date:  2008-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.